Dose-dependent kinetics of methylphenidate enantiomers after oral administration of racemic methylphenidate to rats
- PMID: 2095405
- DOI: 10.1248/bpb1978.13.647
Dose-dependent kinetics of methylphenidate enantiomers after oral administration of racemic methylphenidate to rats
Abstract
The plasma concentration of methylphenidate (MPD) enantiomers after i.v. and oral administration of 0.5-5 mg/kg dose of racemic MPD was compared in rats. In i.v. administration, there was no dose dependence in the pharmacokinetic parameters of both enantiomers in this dose range. In oral administration, although the elimination rate constant of both enantiomers was relatively constant, the total body clearance of both MPD enantiomers decreased remarkably with increasing dose. The relationship between oral dose and the area under the concentration-time curve (AUC) of the individual MPD enantiomers showed a non-linearity. That is, the AUC of both enantiomers increased dramatically with increasing dose more than 2 mg/kg. The recovery (MPD + the metabolite) in urine for 24 h was 16-18% in the range of the oral doses. These results suggest that the dose-dependent characteristics of the MPD enantiomers may be due to the saturation in the presystemic elimination of the drug.
Similar articles
-
Pharmacokinetics and clinical effectiveness of methylphenidate.Clin Pharmacokinet. 1999 Dec;37(6):457-70. doi: 10.2165/00003088-199937060-00002. Clin Pharmacokinet. 1999. PMID: 10628897 Review.
-
Nonlinear kinetics of threo-methylphenidate enantiomers in a patient with narcolepsy and in healthy volunteers.Eur J Clin Pharmacol. 1993;44(1):79-84. doi: 10.1007/BF00315285. Eur J Clin Pharmacol. 1993. PMID: 8436161
-
Kinetic analysis of enantiomers of threo-methylphenidate and its metabolite in two healthy subjects after oral administration as determined by a gas chromatographic-mass spectrometric method.J Pharm Sci. 1990 Jun;79(6):465-9. doi: 10.1002/jps.2600790602. J Pharm Sci. 1990. PMID: 2395090
-
Stereospecific distribution of methylphenidate enantiomers in rat brain: specific binding to dopamine reuptake sites.Pharm Res. 1994 Mar;11(3):407-11. doi: 10.1023/a:1018917205292. Pharm Res. 1994. PMID: 8008708
-
High-dose morphine and methadone in cancer patients. Clinical pharmacokinetic considerations of oral treatment.Clin Pharmacokinet. 1986 Mar-Apr;11(2):87-106. doi: 10.2165/00003088-198611020-00001. Clin Pharmacokinet. 1986. PMID: 3514045 Review.
Cited by
-
A pharmacokinetic model of oral methylphenidate in the rat and effects on behavior.Pharmacol Biochem Behav. 2015 Apr;131:143-53. doi: 10.1016/j.pbb.2015.01.005. Epub 2015 Jan 29. Pharmacol Biochem Behav. 2015. PMID: 25641666 Free PMC article.
-
Acute oral administration of low doses of methylphenidate targets calretinin neurons in the rat septal area.Front Neuroanat. 2015 Mar 23;9:33. doi: 10.3389/fnana.2015.00033. eCollection 2015. Front Neuroanat. 2015. PMID: 25852493 Free PMC article.
-
Pharmacokinetics and clinical effectiveness of methylphenidate.Clin Pharmacokinet. 1999 Dec;37(6):457-70. doi: 10.2165/00003088-199937060-00002. Clin Pharmacokinet. 1999. PMID: 10628897 Review.
-
The effects of adolescent methylphenidate self-administration on responding for a conditioned reward, amphetamine-induced locomotor activity, and neuronal activation.Psychopharmacology (Berl). 2010 Feb;208(3):455-68. doi: 10.1007/s00213-009-1745-7. Epub 2009 Dec 18. Psychopharmacology (Berl). 2010. PMID: 20020108
-
Differentiation of rodent behavioral phenotypes and methylphenidate action in sustained and flexible attention tasks.Brain Res. 2016 Jun 15;1641(Pt B):306-19. doi: 10.1016/j.brainres.2015.11.039. Epub 2015 Dec 10. Brain Res. 2016. PMID: 26688113 Free PMC article.